Meribank Biotech Co Ltd(TW:4724)
NT$9.12-0.13 (-1.41%)
TW:4724
Meribank Biotech Co Ltd Revenue
NT$9.12
At close:-0.13 (-1.41%)
Meribank Biotech Co Ltd (4724) Revenue
Meribank Biotech Co Ltd Revenue
Meribank Biotech Co Ltd had a revenue of 187.13M in the quarter ending Jun 30, 2026, with -15.46%. This bring the company's revenue in the last twelve months to 408.48M, Decreased 13.41%. In the fiscal year ending Dec 31, 2025, Meribank Biotech Co Ltd had annual revenue of 471.76M with 28.75% growth.
- Revenue (ttm)
- 408.48M
- Revenue Growth
- -16.04%
- P/S Ratio
- 1.88
- Revenue/Employee
- TWD 3,322,275
- Employees
- 142
- Market Cap
- TWD 887.78M
Revenue Chart
Meribank Biotech Co Ltd Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 471.76M | 105.33M | 28.75% |
| Dec 31, 2024 | 366.43M | 132.09M | 56.37% |
| Dec 31, 2023 | 234.34M | 54.22M | 30.10% |
| Dec 31, 2022 | 180.12M | 17.04M | 10.45% |
| Dec 31, 2021 | 163.08M | -31.32M | -16.11% |
| Dec 31, 2020 | 194.39M | 33.44M | 20.78% |
| Dec 31, 2019 | 160.95M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.